Emerging evidence for finerenone showcases the drug’s impact on heart failure with mildly reduced ejection fraction and heart failure with preserved ejection fraction.
Catherine E. Cooke, PharmD, MS, BCPS, PAHM
Advertisement
Articles by Catherine E. Cooke, PharmD, MS, BCPS, PAHM
Advertisement
